Skip to main content
. 2017 Oct 27;8(60):102046–102066. doi: 10.18632/oncotarget.22143

Figure 2. In vitro release of GA-S, GA-LP, and Gal-GA-LP.

Figure 2

Notes: (●) GA-S, (■) GA-LP, (▲) Gal-GA-LP, data shown represent the mean ± S.D.

Abbreviations: GA-S, glycyrrhetinic acid solvent; GA-LP, glycyrrhetinic acid liposomes; Gal-GA-LP, glycyrrhetinic acid liposomes modified with liver-targeting ligand of galactosylated derivative.